Assessment of Microfragmented Adipose Tissue Loaded on Bovine Graft Versus Bovine Graft Only on Ridge Preservation.
Launched by CAIRO UNIVERSITY · Jun 10, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a treatment using microfragmented adipose tissue (a type of fat derived from the patient) combined with a bovine graft (a material from cows) works for preserving the bone in the upper jaw after a tooth extraction. The goal is to see if this combination helps maintain the bone better than using the bovine graft alone, which is important for future dental implants. The study will assess changes in the jawbone quality and quantity through imaging and other tests.
To participate in this trial, you need to be over 21 years old and require an implant after losing a tooth due to issues like severe decay or gum disease. You should also have healthy remaining teeth that can support a future dental prosthesis. However, individuals with certain health conditions, poor oral hygiene, or those who smoke heavily may not be eligible. If you join, you’ll be contributing to important research that can help improve dental care for others in the future. Please note that this trial is not yet recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients requiring implant treatment after tooth extraction due to either unrestorable caries lesions or affected periodontium.
- • Age group: above 21 years
- • Remaining natural teeth have good periodontal tissue support and occlusion showed sufficient inter arch space for future prosthesis.
- Exclusion Criteria:
- • General contraindications to implant surgery.
- • Subjected to irradiation in the head and neck area less than 1 year before implantation.
- • Poor oral hygiene and motivation.
- • Severe bruxism or clenching.
- • Systemic, immunologic, or debilitating diseases that could affect normal bone healing \& local pathosis.
- • Treated or under treatment of intravenous amino bisphosphonates.
- • Active infection or severe inflammation in the area intended for implant placement.
- • Patients participating in other studies if the present protocol could not be properly followed.
- • Heavy smokers
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported